Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanyin Pills for stable chronic obstructive pulmonary disease with acute exacerbation endpoint
ChiCTR2100048801Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tanyin Wan in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Time to first acute exacerbation of chronic obstructive pulmonary disease. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
Tanyin Wan
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100048801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048801.